Myriad Genetics Stock Price Prediction
| MYGN Stock | USD 15.71 0.22 1.42% |
Oversold Vs Overbought
21
Oversold | Overbought |
EPS Estimate Current Year 0.1323 | EPS Estimate Next Year 0.1362 | Wall Street Target Price 24.0769 | EPS Estimate Current Quarter (0.01) | Quarterly Revenue Growth 0.112 |
Using Myriad Genetics hype-based prediction, you can estimate the value of Myriad Genetics from the perspective of Myriad Genetics response to recently generated media hype and the effects of current headlines on its competitors.
Myriad Genetics Hype to Price Pattern
Investor biases related to Myriad Genetics' public news can be used to forecast risks associated with an investment in Myriad. The trend in average sentiment can be used to explain how an investor holding Myriad can time the market purely based on public headlines and social activities around Myriad Genetics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Myriad Genetics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Myriad Genetics.
The fear of missing out, i.e., FOMO, can cause potential investors in Myriad Genetics to buy its stock at a price that has no basis in reality. In that case, they are not buying Myriad because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Myriad Genetics after-hype prediction price | USD 15.69 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Myriad |
Myriad Genetics After-Hype Price Prediction Density Analysis
As far as predicting the price of Myriad Genetics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Myriad Genetics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Myriad Genetics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Myriad Genetics Estimiated After-Hype Price Volatility
In the context of predicting Myriad Genetics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Myriad Genetics' historical news coverage. Myriad Genetics' after-hype downside and upside margins for the prediction period are 12.17 and 19.21, respectively. We have considered Myriad Genetics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Myriad Genetics is not too volatile at this time. Analysis and calculation of next after-hype price of Myriad Genetics is based on 3 months time horizon.
Myriad Genetics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Myriad Genetics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Myriad Genetics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Myriad Genetics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.85 | 3.52 | 0.02 | 1.34 | 10 Events / Month | 12 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
15.71 | 15.69 | 0.13 |
|
Myriad Genetics Hype Timeline
Myriad Genetics is now traded for 15.71. The entity has historical hype elasticity of -0.02, and average elasticity to hype of competition of -1.34. Myriad is forecasted to decline in value after the next headline, with the price expected to drop to 15.69. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -0.13%, whereas the daily expected return is now at -0.85%. The volatility of related hype on Myriad Genetics is about 223.67%, with the expected price after the next announcement by competition of 14.37. About 98.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.93. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Myriad Genetics has Price/Earnings To Growth (PEG) ratio of 1.4. The entity recorded a loss per share of 1.28. The firm had not issued any dividends in recent years. Myriad Genetics had 2:1 split on the 26th of March 2009. Given the investment horizon of 90 days the next forecasted press release will be in about 10 days. Check out Myriad Genetics Basic Forecasting Models to cross-verify your projections.Myriad Genetics Related Hype Analysis
Having access to credible news sources related to Myriad Genetics' direct competition is more important than ever and may enhance your ability to predict Myriad Genetics' future price movements. Getting to know how Myriad Genetics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Myriad Genetics may potentially react to the hype associated with one of its peers.
Myriad Genetics Additional Predictive Modules
Most predictive techniques to examine Myriad price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Myriad using various technical indicators. When you analyze Myriad charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Myriad Genetics Predictive Indicators
The successful prediction of Myriad Genetics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Myriad Genetics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Myriad Genetics based on analysis of Myriad Genetics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Myriad Genetics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Myriad Genetics's related companies. | 2023 | 2024 (projected) | Dividend Yield | 0.37 | 0.22 | Price To Sales Ratio | 1.98 | 1.88 |
Story Coverage note for Myriad Genetics
The number of cover stories for Myriad Genetics depends on current market conditions and Myriad Genetics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Myriad Genetics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Myriad Genetics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Myriad Genetics Short Properties
Myriad Genetics' future price predictability will typically decrease when Myriad Genetics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Myriad Genetics often depends not only on the future outlook of the potential Myriad Genetics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Myriad Genetics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 89.9 M |
Check out Myriad Genetics Basic Forecasting Models to cross-verify your projections. To learn how to invest in Myriad Stock, please use our How to Invest in Myriad Genetics guide.You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Myriad Genetics. If investors know Myriad will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Myriad Genetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.28) | Revenue Per Share 9.205 | Quarterly Revenue Growth 0.112 | Return On Assets (0.05) | Return On Equity (0.16) |
The market value of Myriad Genetics is measured differently than its book value, which is the value of Myriad that is recorded on the company's balance sheet. Investors also form their own opinion of Myriad Genetics' value that differs from its market value or its book value, called intrinsic value, which is Myriad Genetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Myriad Genetics' market value can be influenced by many factors that don't directly affect Myriad Genetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Myriad Genetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Myriad Genetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Myriad Genetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.